Difference between revisions of "Part:BBa K1632012:Design"
JunKawamura (Talk | contribs) (→Materials and Methods) |
JunKawamura (Talk | contribs) (→Materials and Methods) |
||
Line 12: | Line 12: | ||
All the samples were DH5α strain with antibiotic resistance to ampicillin and kanamycin.<br> | All the samples were DH5α strain with antibiotic resistance to ampicillin and kanamycin.<br> | ||
− | A. PBAD/araC_FimB(6A1) + | + | A. PBAD/araC_FimB(6A1) +fim switch[default ON](wild-type)_rbs_gfp(3K3) <br> |
− | B. PBAD/araC_FimB(6A1) + | + | B. PBAD/araC_FimB(6A1) +fim switch[default OFF](wild-type)_rbs_gfp(3K3) <br> |
− | C. rbs_M256IcysE(6A1) + | + | C. rbs_M256IcysE(6A1) + fim switch[default ON](wild-type)_rbs_gfp(3K3) …positive control 1<br> |
− | D. rbs_M256IcysE(6A1) + | + | D. rbs_M256IcysE(6A1) + fim switch[default OFF](wild-type)_rbs_gfp(3K3) …negative control 1<br> |
− | E. PBAD/araC_FimB(6A1) + | + | E. PBAD/araC_FimB(6A1) + J23119_rbs_gfp(3K3) …positive control 2 <br> |
F. PBAD/araC_FimB(6A1)+rbs_gfp(3K3) …negative control 2 <br> | F. PBAD/araC_FimB(6A1)+rbs_gfp(3K3) …negative control 2 <br> | ||
Line 36: | Line 36: | ||
10. Add 1 mL of LB containing Amp and Kan, and suspend.<br> | 10. Add 1 mL of LB containing Amp and Kan, and suspend.<br> | ||
11. Add 30 microL of suspension in the following medium.<br> | 11. Add 30 microL of suspension in the following medium.<br> | ||
− | ① 3 mL of LB containing Amp, Kan, glucose (final concentration of mass of glucose is 0.5 percent) and 30 microL of sterile water<br> | + | <span style="margin-left: 20px;">① 3 mL of LB containing Amp, Kan, glucose (final concentration of mass of glucose is 0.5 percent) and 30 microL of sterile water<br> |
− | ② 3 mL of LB containing Amp, Kan and 30 microL of 2 mM arabinose (final concentration of arabinose is 20 microM)<br> | + | <span style="margin-left: 20px;">② 3 mL of LB containing Amp, Kan and 30 microL of 2 mM arabinose (final concentration of arabinose is 20 microM)<br> |
− | ③ 3 mL of LB containing Amp, Kan and 30 microL of 20 mM arabinose (final concentration of arabinose is 200 microM)<br> | + | <span style="margin-left: 20px;">③ 3 mL of LB containing Amp, Kan and 30 microL of 20 mM arabinose (final concentration of arabinose is 200 microM)<br> |
− | ④ 3 mL of LB containing Amp, Kan and 30 microL of 500 mM arabinose (final concentration of arabinose is 5 mM)<br> | + | <span style="margin-left: 20px;">④ 3 mL of LB containing Amp, Kan and 30 microL of 500 mM arabinose (final concentration of arabinose is 5 mM)<br> |
12. Grow the samples at 37 ℃ for 6.5 hours.<br> | 12. Grow the samples at 37 ℃ for 6.5 hours.<br> | ||
13. Measure OD590 of all the samples every hour.<br> | 13. Measure OD590 of all the samples every hour.<br> |
Revision as of 13:37, 15 September 2015
fimB (wild-type)
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
sequence confirmed
Materials and Methods
1.Construction
All the samples were DH5α strain with antibiotic resistance to ampicillin and kanamycin.
A. PBAD/araC_FimB(6A1) +fim switch[default ON](wild-type)_rbs_gfp(3K3)
B. PBAD/araC_FimB(6A1) +fim switch[default OFF](wild-type)_rbs_gfp(3K3)
C. rbs_M256IcysE(6A1) + fim switch[default ON](wild-type)_rbs_gfp(3K3) …positive control 1
D. rbs_M256IcysE(6A1) + fim switch[default OFF](wild-type)_rbs_gfp(3K3) …negative control 1
E. PBAD/araC_FimB(6A1) + J23119_rbs_gfp(3K3) …positive control 2
F. PBAD/araC_FimB(6A1)+rbs_gfp(3K3) …negative control 2
2. Assay protocol
1. Prepare overnight cultures for the each sample in 3 mL of LB medium containing ampicillin (50 microg / mL), kanamycin (30 microg / mL) and glucose (final concentration of mass of glucose is 0.5 percent) at 37 ℃ for 12h.
2. Make a 1:100 dilution in 3 mL of fresh LB containing Amp, Kan and glucose (final concentration of mass of glucose is 0.5 percent).
3.Grow the cells at 37 ℃ until the observed OD590 reaches 0.4 (Fresh Culture)
4. After incubation, take 1 mL of the samples, and centrifuge at 5000x g, 1 min, 25 ℃
5. Remove the supernatant by using P1000 pipette
6. Suspend the pellet in 1 mL of LB containing Amp and Kan, and centrifuge at 5000x g, 1 min, 25 ℃
7. Remove the supernatant by using P1000 pipette
8. Suspend the pellet in 1 mL of LB containing Amp and Kan, and centrifuge at 5000x g, 1 min, 25 ℃
9. Remove the supernatant by using P1000 pipette
10. Add 1 mL of LB containing Amp and Kan, and suspend.
11. Add 30 microL of suspension in the following medium.
① 3 mL of LB containing Amp, Kan, glucose (final concentration of mass of glucose is 0.5 percent) and 30 microL of sterile water
② 3 mL of LB containing Amp, Kan and 30 microL of 2 mM arabinose (final concentration of arabinose is 20 microM)
③ 3 mL of LB containing Amp, Kan and 30 microL of 20 mM arabinose (final concentration of arabinose is 200 microM)
④ 3 mL of LB containing Amp, Kan and 30 microL of 500 mM arabinose (final concentration of arabinose is 5 mM)
12. Grow the samples at 37 ℃ for 6.5 hours.
13. Measure OD590 of all the samples every hour.
14. Start preparing the flow cytometer 1 h before the end of incubation.
15. After the incubation, take the samples, and centrifuge at 9000x g, 1min, 4℃.
16. Remove the supernatant by using P1000 pipette
17. Add 1 mL of filtered PBS (phosphate-buffered saline) and suspend. (The ideal of OD is 0.3)
18. Dispense all of each suspension into a disposable tube through a cell strainer.
19. Use flow cytometer to measure the fluorescence of GFP. (We used BD FACSCaliburTM Flow Cytometer of Becton, Dickenson and Company.)
Source
PCR from MG1655
References
Timothy S. Ham et al. (2006) A Tightly Regulated Inducible Expression System Utilizing the fim Inversion Recombination Switch. Biotechnol Bioeng 94(1):1-4
Hung M. et al. (2014) Modulating the frequency and bias of stochastic switching to control phenotypic variation. Nat Commun 5:4574. doi:10.1038/ncomms5574